Not Tagged
eli lilly
['loxo']
interested in learning about our trial in progress examining a cdk 4/6 inhibitor combined w/ chemoimmunotherapy in pediatric &amp; young adult patients w/ relapsed/refractory #neuroblastoma? see the details here: #asco23 #clinicaltrials #pediatrictumors" 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK